Filing Flows

Filing Flows › Companies › Zevra Therapeutics › Earnings quality

Zevra Therapeutics earnings quality score

How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show

Score15 / 100 · grade E · rank 1027 of 1027

Zevra Therapeutics (ZVRA) scores 15 of 100 for earnings quality, grade E: rank 1027 of 1027 companies and 126 of 126 in health. It loses the most points on accruals of +36.6% of assets, higher than 99% of companies (profit running ahead of cash), Montier C-score 3 of 4 checks failed, discretionary accruals of +39.5% of assets (modified Jones), larger than most. It earns full or near-full marks for profit about as variable as cash flow (smoothness 1.98). Revenue grew 75% in the year: fast growth raises accruals, the Beneish and Dechow scores and the C-score by construction, so a growing company scores lower than a steady one with the same accounting.

What earned and lost points

ComponentWhat the filings showPointsOf
Accrualsaccruals of +36.6% of assets, higher than 99% of companies (profit running ahead of cash)033
Montier C-scoreMontier C-score 3 of 4 checks failed625
Discretionary accrualsdiscretionary accruals of +39.5% of assets (modified Jones), larger than most017
Non-GAAP gapadjusted earnings 60% above GAAP017
Earnings smoothnessprofit about as variable as cash flow (smoothness 1.98)88
ZVRA: share of the available points, by componentZVRA: share of the available points, by componentAccruals1%Montier C-score25%Earnings smoothness100%

How the score is built

Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.

Every company ranked → The full quality workbench, live → Zevra Therapeutics: cash flow →

Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.